Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

被引:14
作者
Wu, Kaiwen [1 ]
Luo, Qiang [2 ]
Liu, Ye [3 ]
Li, Aoshuang [1 ]
Xia, Demeng [3 ]
Sun, Xiaobin [1 ]
机构
[1] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Affiliated Hosp, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China
[2] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Rheumatol & Immunol, Int Sci & Technol Cooperat base Child Dev & Crit D, Chongqing, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Peoples Hosp 7, Dept Pharm, Shanghai, Peoples R China
关键词
Gut microbiota; Gastrointestinal disease; Mendelian randomization; SNPs; INFLAMMATORY-BOWEL-DISEASE; FECAL MICROBIOTA; BUTYRATE; ASSOCIATION; INSTRUMENTS; CHOLESTEROL; PROBIOTICS; STEATOSIS; MOTILITY;
D O I
10.1186/s12967-024-04894-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundRecent research increasingly highlights a strong correlation between gut microbiota and the risk of gastrointestinal diseases. However, whether this relationship is causal or merely coincidental remains uncertain. To address this, a Mendelian randomization (MR) analysis was undertaken to explore the connections between gut microbiota and prevalent gastrointestinal diseases.MethodsGenome-wide association study (GWAS) summary statistics for gut microbiota, encompassing a diverse range of 211 taxa (131 genera, 35 families, 20 orders, 16 classes, and 9 phyla), were sourced from the comprehensive MiBioGen study. Genetic associations with 22 gastrointestinal diseases were gathered from the UK Biobank, FinnGen study, and various extensive GWAS studies. MR analysis was meticulously conducted to assess the causal relationship between genetically predicted gut microbiota and these gastrointestinal diseases. To validate the reliability of our findings, sensitivity analyses and tests for heterogeneity were systematically performed.ResultsThe MR analysis yielded significant evidence for 251 causal relationships between genetically predicted gut microbiota and the risk of gastrointestinal diseases. This included 98 associations with upper gastrointestinal diseases, 81 with lower gastrointestinal diseases, 54 with hepatobiliary diseases, and 18 with pancreatic diseases. Notably, these associations were particularly evident in taxa belonging to the genera Ruminococcus and Eubacterium. Further sensitivity analyses reinforced the robustness of these results.ConclusionsThe findings of this study indicate a potential genetic predisposition linking gut microbiota to gastrointestinal diseases. These insights pave the way for designing future clinical trials focusing on microbiome-related interventions, including the use of microbiome-dependent metabolites, to potentially treat or manage gastrointestinal diseases and their associated risk factors.
引用
收藏
页数:12
相关论文
共 60 条
  • [41] Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review
    Recharla, Neeraja
    Geesala, Ramasatyaveni
    Shi, Xuan-Zheng
    [J]. NUTRIENTS, 2023, 15 (10)
  • [42] Parental inflammatory bowel disease and autism in children
    Sadik, Aws
    Dardani, Christina
    Pagoni, Panagiota
    Havdahl, Alexandra
    Stergiakouli, Evie
    Khandaker, Golam M.
    Sullivan, Sarah A.
    Zammit, Stan
    Jones, Hannah J.
    Davey Smith, George
    Dalman, Christina
    Karlsson, Hakan
    Gardner, Renee M.
    Rai, Dheeraj
    [J]. NATURE MEDICINE, 2022, 28 (07) : 1406 - +
  • [43] Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders
    Sasso, Janet M.
    Ammar, Ramy M.
    Tenchov, Rumiana
    Lemmel, Steven
    Kelber, Olaf
    Grieswelle, Malte
    Zhou, Qiongqiong Angela
    [J]. ACS CHEMICAL NEUROSCIENCE, 2023, 14 (10): : 1717 - 1763
  • [44] Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity
    Sergeev, Igor N.
    Aljutaily, Thamer
    Walton, Gemma
    Huarte, Eduardo
    [J]. NUTRIENTS, 2020, 12 (01)
  • [45] Mendelian Randomization in the Era of Genomewide Association Studies
    Sleiman, Patrick M. A.
    Grant, Struan F. A.
    [J]. CLINICAL CHEMISTRY, 2010, 56 (05) : 723 - 728
  • [46] Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease
    Takahashi, Kenichiro
    Nishida, Atsushi
    Fujimoto, Takehide
    Fujii, Makoto
    Shioya, Makoto
    Innaeda, Hirotsugu
    Lnatorni, Osamu
    Bamba, Shigeki
    Andoh, Akira
    Sugimoto, Mitsushige
    [J]. DIGESTION, 2016, 93 (01) : 59 - 65
  • [47] Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders
    Teofani, Adelaide
    Marafini, Irene
    Laudisi, Federica
    Pietrucci, Daniele
    Salvatori, Silvia
    Unida, Valeria
    Biocca, Silvia
    Monteleone, Giovanni
    Desideri, Alessandro
    [J]. NUTRIENTS, 2022, 14 (02)
  • [48] Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
    Udayappan, Shanthadevi
    Manneras-Holm, Louise
    Chaplin-Scott, Alice
    Belzer, Clara
    Herrema, Hilde
    Dallinga-Thie, Geesje M.
    Duncan, Silvia H.
    Stroes, Erik S. G.
    Groen, Albert K.
    Flint, Harry J.
    Backhed, Fredrik
    de Vos, Willem M.
    Nieuwdorp, Max
    [J]. NPJ BIOFILMS AND MICROBIOMES, 2016, 2
  • [49] Gut microbiota, inflammatory bowel disease and colorectal cancer
    Valencise Quaglio, Ana Elisa
    Grillo, Thais Gagno
    Souza De Oliveira, Ellen Cristina
    Di Stasi, Luiz Claudio
    Sassaki, Ligia Yukie
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (30) : 4053 - 4060
  • [50] Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet
    Wang, J.
    Zhang, H.
    Chen, X.
    Chen, Y.
    Menghebilige
    Bao, Q.
    [J]. JOURNAL OF DAIRY SCIENCE, 2012, 95 (04) : 1645 - 1654